Investment Pitches

Pitch Summary:
@MMMTwealth initiates a first position in Credo, framing it as an undervalued AI infrastructure bottleneck despite optically “expensive” multiples. The core argument is that CRDO sits in interconnect, with management/Street expectations for explosive FY26 financial growth (revenue, EBITDA, net income, and EPS) that can justify premium valuation. He points to technical support around $132 as a favorable entry and argues that 35x EBITDA is reasonable against ~300% EBITDA growth. He also highlights relative resilience during a sector “optics flush,” noting CRDO holding flat while several optical names sold off. A key point is that a prior drawdown was driven by misinformation around “cableless” AI architecture commentary, which he claims is unrelated to Credo. Finally, he argues CRDO is not actually absent from optics—citing product lines in optical DSPs and optics—while remaining positioned to win near-term with AECs and participate in the optical ramp later.

BSD Analysis:
Credo’s setup is a classic “infrastructure bottleneck” trade where share of wallet expands as AI clusters scale and bandwidth/latency constraints tighten. The debate is less about whether multiples look high and more about durability of growth and the company’s ability to sustain gross margin and competitive edge as architectures evolve from copper-heavy to more optical solutions. If AEC adoption is a multi-year bridge and Credo can convert that to platform presence in optical DSP and related products, the business can maintain relevance across technology cycles rather than being a transient component vendor. The key risks are rapid shifts in system design, hyperscaler bargaining power, and competitive responses from larger silicon/optics ecosystems that can bundle solutions. The upside case is credible if CRDO’s product roadmap keeps it embedded as interconnect mixes change, allowing earnings power to compound faster than the market’s skepticism implies.

Actual Post Content:
I just bought into $CRDO for the first time. It's been flashing up in my spreadsheet as undervalued for quite some time and after a bounce off this key support at $132 I thought it was nice. When you have a stock in a bottleneck part of AI (interconnect) set to grow revenues 173% in FY26, EBITDA 300%, net income 310%, and GAAP EPS 550% you take note. When that stock trades for 16x NTM sales, 35x EBITDA, and 42x PE you appreciate it's valued high but you understand it's valued high for a reason. 300% EBITDA growth for 35x EBITDA doesn't even feel that high to me. Then add in the fact that $CRDO has been holding up nicely the last couple days on an optics flush. $COHR down 8% today, $CIEN down 13% and $LITE down 11%... whilst $CRDO is flat. $CRDO did drop ~25% when these other optics stock were ripping before but that was on complete misinformation post CES 2026 keynote when Jensen spoke about Rubin having a cableless design. This is nothing to do with $CRDO. Finally, investors worried about $CRDO's lack of optics when optics is likely set to dominate in 2-3 years. $CRDO are all over optics. They have BlueBird (Optical DSPs) and they have ZeroFlap (optics products). On top of that, they're set to dominate the next 2-3 years with AEC's. Compare $CRDO growth rates in FY26 and FY27 to peers like $COHR and $LITE and it's not that close. $CRDO are set to win the next 2-3 years and they'll also be a key player in optics after that. Long $CRDO.

URL: https://x.com/MMMTwealth/status/2009331730591691261

Pitch Summary:
@ReneSellmann critiques the proposed take-private narrative around InPost, arguing that even after a sharp rally the valuation remains fundamentally too low. He frames the debate around multiples, noting that the stock moving from roughly 8x to 12x forward operating profit still fails to reflect the company’s long-term growth, durability, and execution quality. The author emphasizes InPost’s predictable growth profile and optionality in adjacent markets, suggesting the business could be materially larger over the next decade. From this perspective, he sees potential justification for a €100 per share valuation over time. While acknowledging uncertainty around deal terms, he questions the fairness of a take-private outcome for long-term shareholders. Overall, the stance is bullish on InPost’s intrinsic value but skeptical of any near-term transaction that crystallizes value too early.

BSD Analysis:
InPost’s competitive moat is rooted in its dense parcel locker network, which structurally lowers last-mile delivery costs while improving consumer convenience. As e-commerce penetration continues to rise across Europe, the company benefits from operating leverage and high incremental returns on deployed lockers. The predictability of volumes and capital efficiency supports a higher multiple than traditional logistics peers. The main risk lies in regulatory intervention, competitive responses from integrated couriers, or capital misallocation during expansion. A take-private transaction at modest multiples would transfer long-duration growth optionality away from public shareholders. If InPost remains public and executes, valuation should increasingly converge toward infrastructure-like growth assets rather than commodity logistics operators.

Actual Post Content:
From a valuation POV, the $INPST take-private drama is pretty straightforward to me. Sure, the stock moved up 40% over a few trading days. Nice. You might think that investors should be glad about the developments. Well, here's why I'm not. When I analyzed and valued InPost, I valued the company at an 8x 6-month forward look through EV EBIT multiple. To simplify the math, let's say the stock now trades 50% higher, so it now trades at roughly 12x operating profit. Given the momentum of the business, the long-term growth opportunity, the predictability and durability of the growth, optionality in adjacencies, and management's execution track record, 12x is way too low. What's the right multiple? Hard to say, but I truly believe that $INPST could be a much bigger business a decade from now that would justify a 100 euro per share price. We clearly don't know any deal details, so it's best to wait and see and not to arrive at a definitive judgment of the players involved too quickly. Given the integer.pl background, I must say I'd be surprised if Rafal Brzoska takes the take-private route again below or at IPO price levels. As someone who invested only recently, I can live with both outcomes. But what about those who bought into the stock at 15 euro per share in 2021? Given the business's development, that probably wasn't the worst purchase to make, yet investors would end up with a pretty miserable CAGR over that 4.5 year window. Why not take those investors, who have been invested for several years, believed in the story and execution, and waited patiently, why not take them along for the ride to 100 euro per share? What's to gain here? Brzoska is arguably already a mega rich and influential manager, possibly increasing his stake by a couple of percentage points shouldn't really be the driving force here. I also didn't have the impression that management was bothered by the scrutiny and short-termism that comes with public markets. They are running the business for the long-term. But again, so far all we're seeing is media headlines, and we should possibly give management the benefit of the doubt here until we have more clarity on what's actually going on, what the offer is, etc.

URL: https://x.com/ReneSellmann/status/2009639528881955190

Pitch Summary:
@moninvestor highlights Aeluma as a small-cap semiconductor company gaining momentum, noting a sharp one-day move and increased personal conviction through position sizing. The pitch centers on Aeluma’s compound semiconductor technology platform spanning optoelectronic and electronic devices. He frames the opportunity as broadly exposed to multiple high-growth end markets, including AI, robotics, defense, automotive, and next-generation communications. The author emphasizes that his buying is ongoing and that due diligence is still in progress rather than presenting a fully formed valuation case. The tone is exploratory but constructive, signaling early-stage bullishness driven by technology breadth. Overall, the pitch suggests Aeluma is an emerging semiconductor name worth deeper research rather than a fully priced-in story.

BSD Analysis:
Aeluma’s appeal lies in its positioning at the intersection of compound semiconductors and heterogeneous integration, where performance advantages matter more than scale. Exposure to diverse end markets can be a strength if core process technology is transferable, but it also risks dilution of focus in early commercialization stages. The company’s success will hinge on translating materials science advantages into design wins with repeatable volume potential. For micro-cap semiconductors, capital intensity, customer concentration, and time-to-revenue are the primary risks. If Aeluma can secure anchor customers in one or two verticals, optionality across AI sensing, defense, and AR VR could justify a premium multiple over time.

Actual Post Content:
$ALMU +16.53% today. Aeluma is a semiconductor technology company that develops optoelectronic and electronic devices for sensing, communication, and computing applications. It designs and manufactures semiconductor materials and chips using high-performance compound semiconductor processes. The company’s technology targets a range of markets including mobile devices, automotive systems, artificial intelligence applications, defense and aerospace, robotics, augmented virtual reality, quantum computing, and telecommunications. I first bought the stock on December 29, and I more than doubled my position just two days ago. I’m not finished researching. Thanks, I will look into it. I first bought the stock on December 29. My subscribers found out five days ago during my weekly portfolio update on Friday 2nd January.

URL: https://x.com/moninvestor/status/2009331199790252399

Pitch Summary:
@aleabitoreddit argues Valens Semiconductor is massively mispriced due to a ticker collision error that caused algorithms to believe the company burned $82M in inventory that never existed. He demonstrates mathematically that the balance sheet cannot support that claim and shows VLN is actually a fabless, asset-light semiconductor company with $93.5M in cash, minimal inventory, and no debt. The thesis is reinforced by CES 2026 announcements that expand Valens beyond automotive into robotics, machine vision, and medical, all with shorter sales cycles and materially higher margins. The market is still valuing the company as if it has less than a year of runway, which the author believes is entirely false. He models a $6.5–$7.3 fair value based on conservative EV/revenue multiples for a high-margin AI semiconductor business.

BSD Analysis:
Valens illustrates how automated data ingestion can distort pricing in small-cap semiconductors, especially when ticker collisions contaminate fundamental datasets. As a fabless designer with proprietary DSP IP, its margin structure and capital intensity are fundamentally different from asset-heavy peers. The key upside driver is vertical diversification away from long-cycle automotive programs into robotics and machine vision with faster revenue realization and higher gross margins. Execution risk remains around customer concentration and adoption velocity in non-automotive segments. If revenue and margin mix shift as guided, valuation should normalize toward AI semiconductor peers rather than distressed hardware multiples.

Actual Post Content:
I've initiated a position in $VLN ($155M MC). This one is wild. Valens is a AI semi for self-driving cars and robotics. I've found that markets messed up on VLN from a ticker collision data error. And missed new CES 2026 info this week. VLN has: $93.5M in Cash, 0 Debt. ~$11M inventory. High gross margins ~69.1% CIB ProAV margins, 43.2% automotive. and projected to do $70M plus revenue with blended 63-65% gross margins, jumping from 43% from their automotive pivot from CES. At $155M MC. What. The mispricing was from an analyst scanner typo regarding a $82M inventory burn. VLN is effectively a company with $93.5M Cash and Zero Debt for an EV of ~$65M, while the market has punished it for an inventory crisis that literally does not exist. Streetwise's analysis and other scanners around Nov 13 2025 typo'ed their report when they erroneously stated inventory of US$82 million remained in line with the end of the second quarter. The market and algorithms think VLN is sitting on more than one year of dead inventory and burnt through their cashpile. We can mathematically prove this is a typo using the company's official Q3 2025 balance sheet. Total Assets $136.7M. Cash ~$93.5M. Remaining room for assets $43.2M. If inventory were actually $82M total assets would have to be at least $175M. This inventory figure is mathematically impossible. After looking at their financial reports they are sitting on just ~$11M inventory only selling what they make. Personal opinion is that it should trade at $7 from $2. Warrants are not loans they're potential shares not owed money. This isn’t some random microcap it's a legitimate growing semi with $93m cash and $70m revenue off 60% plus gross margins. I revisited $VLN and modeled ~$6.5 to $7.3 per share using forward EV revenue. This is algorithmic price suppression due to a ticker collision error confusing Valens Semiconductor with Velan Inc. VLN.TO. The new CES information shows robotics and medical verticals using the same DSP core with six month sales cycles and much higher margins. This is my personal thesis based on public information synthesis.

URL: https://x.com/aleabitoreddit/status/2009637599661510665

Pitch Summary:
@rk8215 presents CPS Technologies as a highly underappreciated micro-cap materials company leveraged to multiple secular megatrends including AI data centers, electrification, defense modernization, nuclear energy, and aerospace. The core thesis is that CPSH’s specialized metal matrix composites, armor, and packaging materials occupy critical niches with high switching costs and strong customer relationships. A major catalyst highlighted is a recently awarded $15.5M contract with Infineon, positioning CPSH indirectly within Nvidia’s AI data center supply chain. The company is described as entering an inflection point, having turned profitable, added production capacity, and remained debt-free while scaling demand. Government-funded R&D and SBIR-backed programs provide both validation and non-dilutive funding. While risks include commercialization timing and micro-cap volatility, the author views valuation at roughly 2x revenue as highly asymmetric given the breadth of end-market exposure.

BSD Analysis:
CPS Technologies represents a classic enabling-materials supplier that benefits upstream from AI infrastructure, defense modernization, and electrification trends. Its exposure to data centers is indirect but strategically important, as thermal management and power reliability increasingly constrain AI compute scaling. Defense and nuclear programs provide long-duration funding but introduce revenue lumpiness and customer concentration risk. Differentiation is driven by proprietary composite materials and manufacturing know-how rather than commoditized fabrication, supporting potential margin expansion with scale. Execution risk centers on converting R&D and SBIR programs into repeat commercial revenue. If CPSH sustains growth across even a subset of its addressable megatrends, current valuation may understate long-term earnings power.

Actual Post Content:
$CPSH - Why I Invested in This $60M Micro-Cap Yesterday, I trimmed my $ONDS position and decided to invest in an under-the-radar company I've been eyeing since fellow $DGXX investor @YoYInvestor tweeted about it. The company is CPS Technologies $CPSH, perfectly positioned technically and fundamentally to benefit from megatrends including: Data centers Space exploration Electric vehicles Military aircraft missiles bulletproofing Small nuclear reactors Drones Satellites CPS Technologies Corp is a 40-year-old company based in Norton, MA, developing high-performance materials for mission-critical applications in aerospace, defense 40% of revenue, and commercial sectors like energy and transportation 60%. $CPSH specializes in metal matrix composites MMCs, hermetic packaging, and composite armor, serving blue-chip clients like Raytheon, Lockheed Martin, Infineon, Hitachi, and the U.S. Navy Army. Their products are used via Infineon in $NVDA data center buildouts. They recently secured a $15.5M contract with Infineon. The company is at an inflection point, recently turning profitable and scaling aggressively. It is debt-free, has added a third shift to its facility, and completed a public offering to fund a larger facility to meet demand. Key products with versatile applications: MMCs for thermal management AlSiC baseplates thousands sold weekly for EVs wind farms data centers around 25% market share with growth potential. Hermetic packaging less than 10% share in over $50M market used in satellites and avionics recent 5-axis machining for higher margins. HybridTech Armor patented more than 70% lighter than steel for example 1,000 lbs savings per UH-60 helicopter installed on USS Abraham Lincoln 2024 meets DoD standards. AlMax patent-protected fiber-reinforced aluminum applications in aerospace UAVs vehicles billion dollar markets each SBIR for hybrid EV range improvement. Radiation shielding patented lead-free four billion dollar market Phase 2 SBIR with DOE. They benefit significantly from increased military funding, with the U.S. Army and Navy as major customers funding ongoing development. R and D includes six active DoD DOE projects including nuclear shielding 1.1M missile thermal storage 1M and new 2025 awards like Phase II STTR for warheads and DOE SBIR for nuclear materials. Company is modestly valued at 2x trailing 12-month revenue, with last quarter revenue at 8.8M. What I also like is that insiders have recently bought shares with no sales reported. Risks include delays in commercialization contract dependency supply chain issues macro impacts on spending and micro-cap volatility. IMPORTANT NOTE This is a small position for me DGXX remains around 90% of my portfolio and my main focus I will update followers on major developments. $CPSH may be the most interesting company exposed to the largest amount of megatrends I’ve ever looked at Electrification data centers and EVs defense nuclear satellites and more Most projects have DoD or SBIR support and you’re getting this profitable mega grower for 60M $CPSH components through Infineon are being built on $NVDA AI infrastructure for data center buildouts They just got a $15.5M contract $CPSH just was awarded a $15.5M contract with Infineon a global leader in semiconductor technology $CPSH is their supplier of back end components to Infineon that wind up on $NVDA initiative in their AI data center infrastructure $CPSH also has 6 government contracts with the US Department of Defense US Department of Nuclear Energy and many of the top aerospace and defense contractors like Lockheed Martin Northrop Grumman Raytheon and lastly many big tech companies Since it’s a supply chain relationship with $NVDA through Infineon it does not get the hype like others This will definitely be one of tailwinds going forward TAM is huge

URL: https://x.com/rk8215/status/2009602867737280831

Pitch Summary:
@spacanpanman argues Bridger Aerospace is a highly leveraged wildfire aviation operator that could “break out” in 2026 if EBITDA scales materially. The core bull case is that fleet expansion (Super Scoopers and air-attack aircraft) increases available capacity and utilization, lifting earnings power above what the lone covering analyst currently models. The catalyst is continued aircraft additions plus stronger wildfire seasons that reduce seasonality and support higher government utilization. Valuation is framed as a sensitivity around 2026 EBITDA and an EV/EBITDA multiple, with upside coming from both EBITDA beats and a multiple re-rate as credibility and institutional ownership improve. The implied target range is $5.60–$10.29 per share under $65–$75M EBITDA and 11x–15x multiples. Key risks are utilization not ramping as expected, aircraft acquisition/financing execution, and reliance on government budgets and contracting dynamics despite supportive legislative tailwinds.

BSD Analysis:
Bridger sits at the intersection of a capacity-constrained aerial suppression market and rising wildfire severity, where incremental aircraft and trained crews can translate into step-function revenue opportunities if contracts and utilization are secured. The industry structure is lumpy and procurement-driven, so earnings power depends less on “demand” in the abstract and more on contract access, dispatch rates, and readiness metrics that agencies prioritize. Fleet growth can be value-accretive, but the balance sheet matters: leveraged aircraft purchases amplify upside in strong seasons while increasing refinancing and downtime risk if utilization disappoints. Competitive differentiation likely rests on specialized assets (e.g., scooper capability), maintenance infrastructure, and operational reliability—factors that can support share gains in renewals. The rerating argument ultimately hinges on demonstrating repeatable margins through multiple seasons and proving that new aircraft produce durable incremental EBITDA rather than one-off surge economics. Watch for contract mix (exclusive-use vs call-when-needed), rate resets, and maintenance/availability KPIs as leading indicators of sustainable earnings power.

Actual Post Content:
$BAER: Bridger Aerospace - Highly Leveraged Equity Positioned for 2026 Breakout Simple valuation sensitivity for Bridger Aerospace yields $5.60 to $10.29 per share if the company can 1) grow EBITDA to $65-75M in 2026E and 2) either maintain the current valuation multiple or rerate higher by 1.7x turns of EBITDA. Note: Canaccord is the only analyst covering BAER and has 2026E EBTIDA at $49M, which is way too low. BAER is guiding 2025E EBITDA to be $42-48M and just added 2x Super Scooper and 4x Air Attack planes. The 2x Scoopers alone can generate ~$16M of EBITDA if fully utilized. Note: For 2026E EBITDA I show $50M as the starting point and increase by $5M increments to $80M. I think $65-$75M is a more likely target range. Note: For valuation multiple, I show BAER's current 13.3x 2026E EBITDA in the middle and show a range from 11x - 15x. I believe BAER should trade at the higher end of that range given that 2023-2025E Revenue and EBITDA CAGR has been 34% and 55%, respectively. If management builds credibility and institutional investors start buying shares, the valuation could go above 15x EBITDA. They now own 8x and have 2x on lease w/ option to buy. thank you for all your work on the company! Yes, I think $BAER will continue to purchase more aircraft which will drive revenue and profitability. Fire intensity and frequency is increasing. Seasonality will be less of an issue. In regards to government spending - legislation and the $ being allocated to wildfires is ramping up.

URL: https://x.com/spacanpanman/status/2009365661336637872

Pitch Summary:
@bobspaysubstack revisits his valuation framework for Toast and concludes the stock is unattractive at current prices. He argues that a prior $40 fair value already depended on aggressive long-term assumptions around U.S. restaurant penetration, international expansion, and nearly 50% adjusted EBITDA margins. While acknowledging that such outcomes are possible, he emphasizes that the margin for execution error is thin. He highlights valuation risk, noting Toast trades at a materially higher EV/GAAP EBITDA multiple than peers despite a narrowing gross profit growth advantage. In his view, Toast’s premium multiple is not justified as growth decelerates into the low-20% range. He prefers Block at current levels on relative valuation grounds. He remains open to owning Toast only if the stock declines to $30 or below.

BSD Analysis:
Toast remains a high-quality vertical software platform with deep restaurant workflows, but the debate is no longer about product-market fit and instead about terminal economics. Penetration gains in U.S. restaurants are likely to become incrementally harder as Toast moves beyond early adopters into more price-sensitive operators. International expansion adds optionality but introduces localization, regulatory, and go-to-market complexity that can delay margin realization. The core risk is that consensus embeds software-like margins before competitive intensity, merchant churn, and payments take-rate pressure fully normalize. At elevated EBITDA multiples, even modest deceleration in growth or margin trajectory can compress valuation sharply. The more attractive setup may emerge later, when expectations reset but Toast’s ecosystem strength remains intact. Until then, relative-value investors may prefer peers with lower multiples and comparable growth durability.

Actual Post Content:
Is Toast $TOST Attractive? When I wrote about Toast $TOST back in August, I estimated a fair value of about $40, but that relied on aggressive assumptions: a 40% share of U.S. restaurants by 2034, up from high-teens today; a high-teens share of U.S. food and beverage retail and restaurants for select international markets (Canada, the U.K. and Ireland) by 2034, up from essentially zero today; and a 49% adjusted EBITDA margin by 2034. Can they do it? It's certainly possible, but the margin for error remains small, in my opinion. On an EV/GAAP EBITDA basis, $TOST trades at 35x my 2026 estimate, more than double that of $XYZ, which trades at ~15x, even though the gross profit growth gap between the two is expected to narrow in 2026 with $XYZ up to 16% and $TOST slowing to the low-20% range. As a result, I strongly prefer $XYZ over $TOST at current levels. I would still like to own $TOST but it would have to be at $30, or below. Disclosure: I am long Block $XYZ.

URL: https://x.com/bobspaysubstack/status/2009316115256672264

Pitch Summary:
@ReneSellmann argues Trainline is being priced for terminal decline despite strong current economics. He frames the company as an asset-light rail and coach ticketing platform that monetizes the transaction and interface layer across a fragmented European rail ecosystem. The core bullish angle is valuation: he cites an owner-earnings-style yield around 19% and highlights 80%+ gross margins and strong free-cash-flow characteristics. He also points to growth resilience via international expansion and a higher-margin B2B opportunity, including rapid growth in international B2B and very high EBITDA margins. The catalyst is not a single event but a re-rating as the market regains confidence that disruption fears are overstated relative to fundamentals. He acknowledges meaningful risks, especially UK regulatory change, the threat of contactless ticketing, and platform/AI-driven disintermediation. Overall, the stance is bullish because he believes the downside narrative is already embedded in the price while multiple growth levers remain intact.

BSD Analysis:
Trainline is best analyzed as a two-sided marketplace/retail layer sitting between operators and passengers, where durability depends on (1) access to inventory and (2) owning the default consumer workflow. The biggest structural risk is take-rate compression or channel conflict if governments/operators push a unified retail platform or if contactless becomes the dominant UX in dense corridors, shrinking the value of an intermediary. That said, fragmentation across European operators creates integration complexity and operational friction that often sustains aggregators longer than skeptics expect, especially for cross-border and multi-leg journeys where “best route/price” discovery still matters. The B2B segment could be the quality stabilizer if it scales: higher contractual stickiness, deeper integrations, and less susceptibility to consumer UX shifts can support premium margins. Key diligence items are: operator contract terms/renewals, evidence of repeat usage and brand-driven direct traffic (vs. paid search), and whether product innovation meaningfully reduces customer acquisition cost over time. On valuation, a high headline yield is only “real” if cash conversion is durable through a regulatory cycle and if working-capital/settlement dynamics don’t mask volatility in true owner earnings. A reasonable underwriting frames upside as a normalization of multiple once regulatory outcomes de-risk, and downside as a step-change hit to distribution economics in the UK that also pressures continental negotiating leverage.

Actual Post Content:
I just published a 21,000-word deep dive on Trainline $TRN. The stock trades at a 19% fwd. owner earnings yield, and the market prices it like it's going out of business very soon. But the business is positioned to survive because of its international expansion success and its ambitions in the B2B segment (50% EBITDA margins; growing 55% YoY on the international B2B side). Link below. Company Deep Dives Trainline: An 80%+ Gross Margin Category Leader at a 19% FCF Yield Can this rail aggregator survive various disrupting forces? Rene Sellmann Jan 09, 2026 Paid In the first days of 2026, while most investors were still dusting off their watchlists and refreshing market charts, I stumbled across a new idea that stopped me in my tracks and made me stop everything else I was working on at the time. It was another UK business. The valuation looked almost too attractive to ignore: an asset-light compounder generating 80%+ gross margins, free-cash-flow margins above 25%, and strong and improving reinvestment returns on incremental capital (ROIIC). It has compounded its topline at a 5-year revenue CAGR of 16%, and most importantly, in my Koyfin dashboard it appeared as a 14% FCF yield opportunity (19% according to my H1 annualized “owner earnings” adjustments; as to be discussed in part 5 of the analysis) the EV/Sales multiple collapsed from around 35x at the peak in 2021 to just 2x right now. The stock I’m talking about is British digital rail and coach technology platform Trainline, Europe’s most downloaded rail app (“in a market estimated to be worth around €55 billion“). And arguably, few companies illustrate the tension between structural disruption and secular digitization tailwinds quite like this business. On one side, you have a pan-European travel marketplace with 27 million active users, 270+ operator integrations, and gross margins north of 80%. On the other, a UK rail system in political overhaul, creeping contactless ticketing that bypasses apps entirely, mobility behemoth Uber entering the space three years ago, and a Google search funnel that has already shown it can shift traffic dynamics with a UI update. Put differently, the numbers suggests this is a “high-quality compounder.” The narrative and current sentiment, however, tells you there’s serious “middleman & disruption risk.” And in 2025, the market made it clear which version it feared most: the stock price roughly halved down 60% from a prior peak as regulatory uncertainty took centre stage. Trainline’s de-rating isn’t the result of collapsing demand or evaporating margins. It’s the result of five structural debates that question whether this business model can still capture value when the rails go digital, centralized, or AI-navigated. These debates have created one of the most asymmetric setups in UK travel-tech: a business that has already demonstrated post-pandemic profitability, but hasn’t yet demonstrated immunity to disruption especially in a core market being redesigned by public policy and influenced by external platforms. And while the market prices uncertainty quickly, marketplaces like Trainline only earn back credibility slowly, through evidence, great economics, and durable customer habits. To understand why this stock polarizes opinion so aggressively, you need to understand what Trainline is and what it isn’t. We’ll discuss this in great detail in this analysis, but from a high-level POV: It doesn’t run trains. It doesn’t own coaches. It doesn’t set ticket prices. It doesn’t hold inventory. What it does own is the transaction layer, the operator connectivity graph, and the user interface that simplifies a highly fragmented industry. It’s a typical aggregator business. Trainline captures a small slice of a huge rail ticketing and journey ecosystem a category estimated to be worth tens of billions in Europe (€55 billion according to a C&C analysis) and still structurally shifting online. This is not a stock for people who want easy answers. This is a stock for people who want nuanced answers to the right set of questions. And arguably, those questions are the five debates outlines below that will ultimately determine whether Trainline is mispriced, misunderstood, or merely early in a sentiment recovery cycle: Can a UK government platform unseat an independent aggregator? How far can contactless ticketing spread before app-based retail becomes optional, not default? Are pan-European corridor wins enough to prove scalable continental relevance? Is integration-depth friction strong enough to defend a moat when AI assistants can shortcut search? Can margins expand further while commissions compress, or do take-rates ultimately reset downward? My goal in the full post below is not to pick a side emotionally, but to stress-test each question carefully. It seems like there is a massive disconnect between the share price and the financials the company actually delivered and this is exactly why Trainline has become one of the most interesting travel-tech stocks in Europe. Here are the topics I’ll explore in this comprehensive 21,000-word analysis: The 90-second “Bam Bam Bam Bam Bam” pitch how the stock can be pitched in under two minutes, and what makes it intriguing right now. What the business actually is, beyond the simplification of being a ticketing app (segment analysis, geographical mix, product, customers, etc.) How carrier integrations shaped Trainline’s expansion and market positioning (in the past and today) The economics of being a travel intermediary that doesn’t own trains, tracks, or coaches & why the model shows negative working capital dynamics How the UK and Europe differ in adoption maturity, monetization, and app entrenchment Comprehensive competitive advantage analysis Competitive pressures, moat stack, supplier leverage, and whether the moat is narrowing or expanding in different geographies Management background, compensation, ownership, capital allocation behaviour through crisis, and capital return discipline What the balance sheet reveals about settlement timing, capital intensity, and impairment sensitivity Maybe most importantly, a nuanced discussion of risks & the five key debates outlined above. My own valuation work key variables and assumptions & the long-term growth levers that drive long-term value My “owner earnings” estimates which are based on a couple of adjustments, producing a higher effective yield than the one showing up in investment terminals Detailed segment modelling A multi-stage TSR model (downloadable so you can make your own adjustments) Where this business sits in its life cycle, and why optionality in adjacencies exists I’d suggest looking at the recent financial statements yourself.

URL: https://x.com/ReneSellmann/status/2009298442976465271

Pitch Summary:
@ZeeContrarian1 argues that Protalix is a deeply underfollowed micro-cap biotech that has quietly completed a multi-year turnaround. The company now has two commercial rare-disease enzyme replacement therapies and a pipeline gout drug that provides asymmetric optionality. The core value is driven by ELFABRIO in Fabry disease, where royalties could scale to meaningful, high-margin cash flow by the end of the decade. Additional upside comes from the Gaucher therapy once a legacy, low-margin Pfizer agreement expires or is renegotiated. The author frames the valuation as disconnected from fundamentals, given minimal analyst coverage and a market cap well below discounted cash flow estimates. Insider buying by the CEO is cited as further validation of confidence in the long-term plan. Risks include clinical failure of the gout program, execution on royalty ramp, and the long-dated nature of some catalysts, but the overall stance is strongly bullish.

BSD Analysis:
Protalix represents a rare case of a commercial-stage biotech trading closer to pipeline optionality than to cash-generating assets. The Fabry franchise is the anchor, offering durable orphan-drug economics, long patient duration, and limited competitive churn once patients are stabilized. Royalty-based structures materially reduce commercial risk while preserving operating leverage, which can drive outsized EBITDA as volumes scale. The Gaucher asset is strategically mispriced due to historical contract terms, but embedded renegotiation optionality provides a free call on margin expansion later this decade. The gout program is non-core to valuation today but meaningful if efficacy or safety differentiation versus incumbents is demonstrated. The main risks are time, capital allocation discipline, and dependence on partners for commercialization momentum. If management sustains capital discipline and converts royalties into visible free cash flow, the multiple should migrate toward profitable orphan-drug peers rather than early-stage biotech comps.

Actual Post Content:
Protalix Biotherapeutics $PLX Today we dig into a biotech stock that didn’t move, both globally and especially in Israel. These are two markets that performed very well overall, yet still left a few companies behind. Shall we begin? $PLX is a micro-cap biotech trading at a market cap of roughly $140M and an enterprise value of only ~$110M. The company is cash-flow balanced. We often use the term under the radar loosely, but $PLX truly redefines it. A simple search on Bloomberg shows that only three analysts cover the stock, all from very small and obscure research houses. The situation is so extreme that Bloomberg’s FA function shows estimates only through next year, and even those are barely meaningful. This is not the $PLX you may remember. About 6.5 years ago, after a series of business mistakes brought the company close to bankruptcy, $PLX hired an experienced executive from $TEVA Pharmaceutical Industries, Dror Bashan, as CEO. Since then, quietly and perhaps too quietly, he has turned the company around. Today, $PLX has three core assets. Asset number one Gaucher disease drug sold via direct sales to the Brazilian government and via Pfizer. The zero-margin Pfizer contract expires in 2030, implying at least $5M incremental annual profit thereafter, with upside if the product is reclaimed. Asset number two Fabry disease ERT drug ELFABRIO sold by Chiesi with royalties and milestones. The Fabry ERT market is near $2B annually and PLX expects roughly $100M annual revenue at ~90% operating margins by 2030. Asset number three is a gout drug targeting better efficacy and safety than Amgen’s therapy, with Phase 2 data expected in 2027. With high probability, $PLX should reach roughly $100M in EBITDA by 2030 from commercial assets alone. Discounted, this implies roughly $450M valuation, with milestones and Pfizer optionality pushing toward $500M. The gout drug alone, at low probability, adds ~$100M in value. CEO insider buying reinforces conviction. Bottom line go buy.

URL: https://x.com/ZeeContrarian1/status/2009308510216180000

Pitch Summary:
As mentioned earlier, we added Sea Limited (SE) in 4Q25. Sea Limited represents our newest conviction play on Southeast Asia's (SEA) digital transformation. What began as a gaming company (Garena) has evolved into an integrated ecosystem spanning e-commerce (Shopee) and digital financial services (Monee), each reinforcing the others. Shopee dominates SEA e-commerce with ~52% market share, having outmaneuvered Alibaba's Lazada through relentless hyper-localization and strategic cost discipline. Rather than chasing premium positioning, Shopee weaponized efficiency to win: filling trucks only when full, building networks of small sorting centers instead of mega-warehouses, and focusing on high-density urban routes. This counter-positioning created a logistics moat that competitors are struggling to replicate while Shopee's transaction data feeds Monee's credit scoring, enabling superior lending decisions with NPLs consistently below 2%. Sea Limited’s business has reached an inflection point, with e-commerce take-rates climbing to 13.3%, digital financial services EBIT margins reaching 28%, and gaming stabilizing and recovering. At current prices following a ~40% drawdown, assuming 20% revenue growth into 22% free cash flow margins, we project attractive ~27% annualized returns over the next five years.

BSD Analysis:
Sea is no longer the reckless growth story it once was — survival taught discipline fast. Shopee remains a dominant e-commerce platform in Southeast Asia, even as competition stays fierce. Management proved it can generate real profits when it stops chasing market share at any cost. Garena adds optionality when gaming cycles cooperate. SeaMoney deepens ecosystem economics, though execution must stay tight. Currency volatility and regulation are permanent features, not temporary setbacks. The business now prioritizes unit economics over vanity metrics. This is not a clean compounder yet. It’s an execution story that finally makes sense.

Pitch Summary:
Tesla is a leading artificial intelligence company with formidable competitive advantages across electric vehicles, software, and energy storage. Guided by Elon Musk, Tesla has embraced a scale-economies-shared business model, strategically reducing prices to accelerate adoption and expand its total addressable market. With its distinctive innovations, vast operational scale, and impressive cost efficiencies, Tesla is steadily eroding the foundations of entrenched legacy automakers. We believe Tesla’s AI capabilities remain underestimated and that the company is at the beginning of a hypergrowth phase. We anticipate Tesla will operate millions of autonomous vehicles, license self-driving software at 70–80% margins, and scale substantially in robotics.

BSD Analysis:
Tesla is no longer just an EV company — it’s a vertically integrated platform spanning manufacturing, software, energy storage, and autonomy. Vehicle margins have compressed, but Tesla’s cost structure still leads the industry. The real debate is whether autonomy and AI-driven software monetization materialize at scale. Energy storage is becoming a meaningful profit contributor with strong demand visibility. Competition is intense, but Tesla’s brand, data advantage, and manufacturing learning curve remain differentiators. Volatility is part of the package. Tesla is a long-dated option on autonomy layered on top of a global auto and energy business.

Pitch Summary:
In 2024, we initiated a position in QXO at approximately $11 per share. Under Brad Jacobs’ leadership, the company is in the early stages of executing a bold plan to consolidate and disrupt the $800 billion building products distribution industry. Having previously invested in two of Brad’s highly successful ventures—United Rentals and XPO Logistics—we are excited to back his latest endeavor. In August 2025, QXO completed its first acquisition: Beacon Roofing Supply, Inc., purchased in an all-cash deal valued at approximately $11 billion. Brad and his team have already implemented operational changes at Beacon, including streamlining its nine-level legacy organizational chart. We expect the team to expand Beacon’s EBITDA margins by about 500 basis points and to double cash flow within four years. Ultimately, we envision QXO achieving over $50 billion in revenue with returns on capital of 17–23%.

BSD Analysis:
QXO is an early-stage roll-up platform targeting building-products distribution, aiming to apply technology and scale to a fragmented, low-efficiency industry. The thesis is execution-driven: consolidate assets, improve pricing discipline, and modernize operations. Early days mean limited financial visibility, but also maximum optionality. Management pedigree and capital backing matter more than near-term numbers. If consolidation works, operating leverage can be powerful. If not, returns compress quickly. This is a founder-led, strategy-first story where patience is mandatory.

Pitch Summary:
Brookfield Corporation, headquartered in Toronto, Canada, stands as a preeminent global alternative asset manager and operator, harnessing a vast permanent capital base of over $180 billion to invest in and scale high-quality businesses across infrastructure, renewable power, private equity, real estate, and beyond. With more than $1 trillion in assets under management through its majority-owned asset management arm and a growing $135 billion insurance solutions platform, the company deploys patient, opportunistic capital into real assets that power the global economy. Brookfield’s culture of disciplined value creation and long-term stewardship serves as its bedrock competitive moat. We are confident that Brookfield is on track to achieve its ambitious five-year targets, supported by robust fundraising, accelerating fee-related earnings growth, and disciplined deployment of capital at attractive internal rates of return. Under the steady hand of CEO Bruce Flatt, Brookfield exemplifies the rare blend of scale, sophistication, and shareholder alignment that defines exceptional businesses.

BSD Analysis:
Brookfield is one of the world’s most sophisticated alternative-asset managers, specializing in hard assets with long-duration cash flows. Infrastructure, renewable power, private credit, and real estate form a diversified engine that thrives on scale and operational expertise. Brookfield benefits from volatility because distress creates buying opportunities for patient capital. Fee-related earnings are growing steadily while balance-sheet investments add upside. The organization’s capital allocation discipline is a true moat. Complexity keeps the valuation discounted. Brookfield is a long-term compounding machine for investors willing to think in decades.

Pitch Summary:
We initiated our Apple investment in 2016 and elevated it to a core holding in 2018, the same year the company unveiled its redesigned 13-inch and 15-inch MacBook Pro models. Under Tim Cook’s far-sighted leadership, Apple has continually redefined innovation across hardware and software. Today, Apple’s ecosystem powers about 2.4 billion active devices, bolstered by a rapidly expanding subscription services base. This approach has supercharged customer engagement and spending. In fiscal 2025 (ended September), the high-margin, stable subscription services segment accounted for roughly 42% of total gross profits, up from about 39% the previous year. The September 2025 iPhone 17 launch—featuring the iPhone 17, iPhone 17 Pro, iPhone 17 Pro Max, and the new ultra-thin iPhone Air—has posted one of the strongest early sales cycles in recent years. Key drivers include the A19 chip, larger displays, and 120Hz refresh rates across all models. We expect rising revenues from new product launches, services, margin expansion, and share repurchases to fuel approximately 10% annual growth in earnings per share over the next several years. A decade after we first purchased shares, we believe Apple remains one of the highest-quality businesses on the planet.

BSD Analysis:
Apple remains the most powerful consumer-tech ecosystem ever built, monetizing hardware, services, and silicon within a closed-loop platform. Services growth provides margin stability and offsets hardware cyclicality. Apple’s control over custom chips keeps performance leadership in-house and reduces supplier risk. The installed base continues to expand, reinforcing pricing power and upgrade cadence. Regulatory pressure around app economics is rising but unlikely to dismantle the ecosystem. Cash generation supports massive buybacks and strategic flexibility. Apple is no longer a growth rocket — it’s a global toll booth with extraordinary durability.

Pitch Summary:
Established in 1994 by Jeff Bezos within the humble confines of his garage, Amazon has evolved into a colossus that commands unparalleled dominance across its diverse markets. Despite its immense scale, the company’s e-commerce arm continues to capture additional market share with remarkable agility. Meanwhile, its cloud computing powerhouse, Amazon Web Services (AWS), stands as the undisputed leader in its domain. We estimate that AWS currently accounts for more than 50% of Amazon’s aggregate operating profits. Both the retail operations and AWS have significant competitive advantages and offer exceptional value to customers. Eschewing the temptation to exploit its vast stature for immediate profit maximization, Amazon embraces a scale-economies-shared business model, generously redistributing a substantial share of its margins back to consumers. This strategic benevolence ignites a virtuous flywheel, perpetually strengthening the company’s ecosystem. By channeling substantial investments into its operations today to create even greater shareholder value tomorrow, Amazon obscures the true magnitude of its latent earnings potential. As shoppers increasingly pivot from brick-and-mortar retail to digital marketplaces, and as vast troves of data transition from local servers to cloud environments, we anticipate that Amazon’s revenues will expand at a compound annual growth rate of approximately 10% over the next five years, with earnings per share poised to more than double during that timeframe.

BSD Analysis:
Amazon has quietly entered its most profitable phase, with cost discipline and automation finally matching its scale. AWS remains the backbone of global cloud and AI workloads, providing high-margin growth even as enterprise spend moderates. Retail margins are improving as logistics networks regionalize and inventory discipline tightens. Advertising has become a major profit driver, monetizing traffic Amazon already owns. Regulatory scrutiny is constant but has not altered consumer behavior or merchant reliance. Free cash flow is inflecting meaningfully. Amazon is transitioning from empire-builder to cash-flow compounder.

Pitch Summary:
During the quarter AUB received an unsolicited non-binding indicative proposal to acquire the business for $45.00 per share from a private equity bidder. The share price rose sharply following the announcement before falling back when the offer was terminated a month later. We have owned AUB since 2009 and it has been a solid long-term performer for the fund. While the withdrawal of the takeover offer removed a short-term catalyst, it was welcome news as it allows the company to continue compounding value independently.

BSD Analysis:
AUB Group is a high-quality insurance distribution platform built around underwriting agencies, broker services, and equity stakes rather than direct risk-taking. Its model scales with premium growth while avoiding the balance-sheet volatility of insurers. Rising insurance pricing cycles directly benefit AUB through higher commissions and earnings visibility. The company’s decentralized structure keeps founders and managers highly aligned, supporting strong retention and organic growth. M&A remains disciplined and accretive, focused on niche agencies with defensible books. Cash flow is consistent and capital-light. AUB is one of the best compounders in global insurance intermediation.

Pitch Summary:
Bravura Solutions was recently added to the portfolio following the release of its full year results which disappointed the market and saw the shares marked down sharply. The company reported revenues of $256m, up 3%, while operating profits surged 96% to $50m. Bravura has no debt and has initiated a policy to pay at least 50% of net profit as dividends. The mission-critical nature of its software creates extremely high switching costs for customers. Since the 2023 investment by Pinetree Capital and Damian Leonard, profitability has improved materially through overhead reduction, and a new CEO from within the Constellation Software ecosystem has been appointed.

BSD Analysis:
Bravura provides mission-critical software for wealth management, pensions, and fund administration, where switching costs are enormous. The company has struggled with execution in the past, but the underlying products remain deeply embedded at clients. Industry consolidation and regulatory complexity support long-term demand. Revenue visibility is improving as implementations stabilize. Margin recovery depends on cost discipline and delivery consistency. The valuation reflects skepticism rather than terminal decline. Bravura is a turnaround software story with real underlying asset value.

Pitch Summary:
Eagers fell 16% during the quarter after announcing a $1.0 billion investment to buy a 65% stake in CanadaOne and undertaking a $500m capital raising to help fund the purchase. Despite the short-term share price reaction, Eagers has easily been the best performer and largest contributor to fund performance for the past calendar year, with shares rising from under $12 to nearly $25 while also paying 74c in fully franked dividends. CanadaOne operates 42 dealerships across five Canadian provinces and benefits from a structurally less competitive market than Australia. A key attraction is that CanadaOne covers fixed costs through its service departments before selling a single car, unlike the Australian model. The business also operates a dealer partner model that strongly aligns local management incentives.

BSD Analysis:
Eagers is Australia’s largest automotive dealership group, benefiting from industry consolidation and strong OEM relationships. The company has diversified earnings through used cars, servicing, and financing, reducing reliance on new vehicle cycles. Pricing power improved during supply-constrained periods and normalized more gracefully than expected. Management has been opportunistic in M&A, buying dealerships at attractive returns. EV transition adds complexity but also new service revenue streams. Cash generation remains solid across cycles. Eagers is a scale-driven consolidator in a fragmented retail industry.

Pitch Summary:
We attended the company’s AGM at their new facility in October and came away very impressed. This facility should allow the company to grow for many years to come, and it is always informative to chat with some of the line staff that we don’t get to see during the year. The company also outlined some of the new rule changes for F1 for the coming season which can only benefit the company. During December the company announced that the current Chief Financial Officer (CFO) Sharyn Williams will become the new Chief Executive Officer (CEO) taking over from the current interim CEO Matthew Bryson. While this was an unusual appointment given the technical nature of the business, we are reassured that founder Kees Weel remains Executive Chairman and Matthew Bryson remains Chief Technical Officer, with both retaining large shareholdings.

BSD Analysis:
PWR is a premium motorsport and automotive thermal-solutions provider, supplying high-performance cooling systems to elite racing and specialty OEM customers. Its engineering capabilities and bespoke manufacturing create a defensible niche with pricing power. Growth is supported by motorsport demand, defense applications, and EV thermal management. Margins are strong due to customization and technical complexity. Customer concentration exists but relationships are long-standing. Expansion into adjacent markets adds optionality. PWR is a small-cap industrial with global reputation and high-quality execution.